Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06432959 · ClinicalTrials.gov registry record · NA
Incorporating Positive Affect Promoting Activities Into Cognitive Behavioral Therapies
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT06432959: Completed NA study, sponsored by Ohio State University.
NCT06432959 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06432959, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
In this study, the investigators will test whether the incorporation of positive affect promoting activities in treatment sessions improves outcomes in the context of CBT for depression and DBT for problems of emotion dysregulation. In clinics focused on each of these treatments, the investigators will evaluate these treatments with and without the addition of positive affect promoting activities.
Primary Outcome
16 item self-report assessment of symptoms of depression with each item scored on a 0-3 scale. Higher scores indicate more severe symptoms of depression.
Interventions
- BEHAVIORAL Psychotherapy
- BEHAVIORAL Psychotherapy, Positive Affect Promoting Activities
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2024-04-01 |
| Phase | NA |
What the finished NCT06432959 record still lists
NCT06432959 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Psychotherapy is the first listed.
NCT06432959 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06432959 about?
NCT06432959 is a clinical study titled "Incorporating Positive Affect Promoting Activities Into Cognitive Behavioral Therapies". In this study, the investigators will test whether the incorporation of positive affect promoting activities in treatment sessions improves outcomes in the context of CBT for depression and DBT for problems of emotion dysregulation. In clinics focused on each of these treatments, the investigators w...
What is the current status of trial NCT06432959?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2022-09-01. Estimated completion is 2024-04-01.
What interventions are being tested in trial NCT06432959?
The interventions under investigation include: Psychotherapy (BEHAVIORAL), Psychotherapy, Positive Affect Promoting Activities (BEHAVIORAL).
Who is sponsoring clinical trial NCT06432959?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06432959's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI